0001104659-22-011497.txt : 20220203
0001104659-22-011497.hdr.sgml : 20220203
20220203190610
ACCESSION NUMBER: 0001104659-22-011497
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TYLE PRAVEEN
CENTRAL INDEX KEY: 0001296936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 22590283
MAIL ADDRESS:
STREET 1: ONE BAUSCH & LOMB PLACE
CITY: ROCHESTER
STATE: NY
ZIP: 14604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1371 EAST 2100 SOUTH
STREET 2: SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84105
BUSINESS PHONE: (781) 788-8869
MAIL ADDRESS:
STREET 1: 1371 EAST 2100 SOUTH
STREET 2: SUITE 200
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84105
FORMER COMPANY:
FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060811
4
1
tm225348d9_4.xml
OWNERSHIP DOCUMENT
X0306
4
2022-02-01
0
0001372514
KIORA PHARMACEUTICALS INC
KPRX
0001296936
TYLE PRAVEEN
C/O KIORA PHARMACEUTICALS, INC.
1371 E. 2100 SOUTH, SUITE 200
SALT LAKE CITY
UT
84105
1
0
0
0
Stock Option (right to buy)
0.77
2022-02-01
4
A
0
5000
0
A
2032-02-01
Common Stock
5000
5000
D
The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023.
/s/ Sarah Romano, Attorney-in-Fact*
2022-02-03